Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Journal: Nature Medicine

Published: 2020-06-05

DOI: 10.1038/s41591-020-0949-6

Affiliations: 18

Authors: 22

Go to article
Institutions Share
Nanfang Hospital, China 0.22
Guangzhou Kingmed Diagnostics Center Co. Ltd., China 0.09
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital (SAMSPH), China 0.09
National Clinical Research Center for Kidney Disease at Nanfang Hospital, SMU, China 0.09
Foshan First People's Hospital, China 0.05
The People's Hospital of Honghu, China 0.05
The First People’s Hospital of Jingzhou, China 0.05
Jingzhou Central Hospital, China 0.05
Honghu Traditional Chinese Medicine Hospital, China 0.05
The Second People's Hospital of Honghu, China 0.05
The Hong Kong Polytechnic University (PolyU), China 0.05
Tsinghua University, China 0.05
University of Electronic Science and Technology of China (UESTC), China 0.05
Chongqing Medical University (CQMU), China 0.05
Guangzhou Institutes of Biomedicine and Health (GIBH), CAS, China 0.03
Macau University of Science and Technology (MUST), China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER